New targets for type 2-low asthma
Quang Luu Quoc, Youngwoo Choi, Gyu-Young Hur, Hae-Sim Park
Korean J Intern Med. 2024;39(2):215-227. Published online 2024 Feb 6 DOI: https://doi.org/10.3904/kjim.2023.299
Citations to this article as recorded by 
Updated biomarkers for extracellular traps from neutrophil, monocyte, and M1 macrophage in neutrophilic asthma: a narrative review
Quoc Quang Luu, Thi Bich Tra Cao, Hae-Sim Park, Duy Le Pham
MedPharmRes.2025; 9(1): 1. CrossRef
Established and Emerging Asthma Biomarkers with a Focus on Biologic Trials: A Narrative Review
Philip F. Lavere, Kaitlin M. Phillips, Nicola A. Hanania, Muhammad Adrish
Journal of Personalized Medicine.2025; 15(8): 370. CrossRef
Breaking the steroid barrier: Emerging biomarkers and targeted therapies for type 2-low asthma
Rahul Garg
Annals of the National Academy of Medical Sciences (India).2025; 61: 329. CrossRef
Association of Peripheral Blood Eosinophils and Neutrophils with Asthma Phenotype among School-Aged Children
Jafar Wafi Janak, Hawraa Fadhil Abbas, Haidar A.N. Abood, Suhaila Rayhaan
Journal of Preventive, Diagnostic and Treatment Strategies in Medicine.2025; 4(4): 334. CrossRef
T cell heterogeneity in asthma pathogenesis: from immunological mechanisms to biological targeted therapies
Qifeng Gan, Yuzhen Zhu, Yuxin Guo, Guo Fu, Xiao-Bin Zhang
Frontiers in Immunology.2025;[Epub] CrossRef